Last edition
News about "Yuvezzi"
Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialise YUVEZZI in Europe
Lupin and Tenpoint Therapeutics partner to commercialise YUVEZZI in the European Union (EU), The UK, Switzerland, Norway, and Iceland and expand access to the once-daily dual-agent eye drop for presbyopia.
YUVEZZI | 20/08/2026 | By News Bureau
FDA Approves Tenpoint Therapeutics' Yuvezzi, First Dual-Action Eye Drop for Presbyopia
The US FDA has approved Yuvezzi (carbachol and brimonidine tartrate), the first dual-agent eye drop for presbyopia, offering significant near-vision improvement with favourable tolerability.
Yuvezzi | 31/01/2026 | By News Bureau | 386
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy